Heshui Yu

2.0k total citations
114 papers, 1.6k citations indexed

About

Heshui Yu is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Heshui Yu has authored 114 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Molecular Biology, 28 papers in Complementary and alternative medicine and 27 papers in Pharmacology. Recurrent topics in Heshui Yu's work include Natural product bioactivities and synthesis (32 papers), Phytochemical Studies and Bioactivities (25 papers) and Traditional Chinese Medicine Analysis (22 papers). Heshui Yu is often cited by papers focused on Natural product bioactivities and synthesis (32 papers), Phytochemical Studies and Bioactivities (25 papers) and Traditional Chinese Medicine Analysis (22 papers). Heshui Yu collaborates with scholars based in China, United States and United Kingdom. Heshui Yu's co-authors include Baiping Ma, Liping Kang, Yang Zhao, Cheng‐Qi Xiong, Xinbo Song, Xu Pang, Wenzhi Yang, Zheng Li, Jie Zhang and Lifeng Han and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Heshui Yu

104 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heshui Yu China 23 1.0k 318 274 268 263 114 1.6k
Baiping Ma China 27 1.8k 1.7× 301 0.9× 419 1.5× 517 1.9× 330 1.3× 174 2.4k
Lifeng Han China 22 770 0.8× 333 1.0× 369 1.3× 81 0.3× 171 0.7× 73 1.5k
Xu Pang China 21 786 0.8× 137 0.4× 212 0.8× 185 0.7× 183 0.7× 89 1.4k
Liqin Ding China 24 886 0.9× 373 1.2× 305 1.1× 115 0.4× 98 0.4× 88 1.7k
Jiayu Zhang China 25 1.0k 1.0× 360 1.1× 461 1.7× 49 0.2× 196 0.7× 90 1.7k
Jian Han China 27 1.4k 1.4× 624 2.0× 796 2.9× 155 0.6× 326 1.2× 56 2.3k
Nicola Fuzzati Italy 22 947 0.9× 317 1.0× 677 2.5× 90 0.3× 92 0.3× 35 1.6k
Yong‐Gang Xia China 29 995 1.0× 536 1.7× 997 3.6× 91 0.3× 101 0.4× 113 2.1k
Minjian Qin China 25 991 1.0× 330 1.0× 629 2.3× 46 0.2× 171 0.7× 119 1.8k

Countries citing papers authored by Heshui Yu

Since Specialization
Citations

This map shows the geographic impact of Heshui Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heshui Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heshui Yu more than expected).

Fields of papers citing papers by Heshui Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heshui Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heshui Yu. The network helps show where Heshui Yu may publish in the future.

Co-authorship network of co-authors of Heshui Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Heshui Yu. A scholar is included among the top collaborators of Heshui Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heshui Yu. Heshui Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lü, Ming, Shi Chen, Ruobing Liu, et al.. (2025). Synthesis, Characterization and Evaluation of Resveratrol-Loaded Functionalized Carbon Nanoparticles for Extending Yeast Lifespan. ACS Omega. 10(25). 26458–26467.
2.
Bian, Xiaohui, et al.. (2025). Ethnomedicine, Botany, Phytochemistry, Pharmacology, Pharmacokinetics, and Toxicity of Rhizoma Corydalis: A Systematic Review. The American Journal of Chinese Medicine. 53(5). 1441–1476.
3.
Xü, Qiang, et al.. (2025). A comprehensive review of Intelligent Question-Answering Systems in Traditional Chinese Medicine Based on LLMs. Journal of Pharmaceutical Analysis. 101406–101406.
6.
Yuan, Hui, Ming‐Chi Lu, Zhenjiang Yao, et al.. (2025). Plumbagin disrupts the mature biofilm of Staphylococcus aureus. Biofouling. 41(10). 1132–1144.
7.
Yuan, Hui, Ming‐Chi Lu, Zhenjiang Yao, et al.. (2025). Antibiofilm activity of Plumbagin against Staphylococcus aureus. Scientific Reports. 15(1). 7948–7948. 2 indexed citations
8.
Yuan, Hui, et al.. (2024). Interactions of plumbagin with five common antibiotics against Staphylococcus aureus in vitro. PLoS ONE. 19(1). e0297493–e0297493. 4 indexed citations
10.
Lei, Peng, Xiaoge Li, Lei Jiang, et al.. (2024). Alisma plantago-aquatica polysaccharides ameliorate acetaminophen-induced acute liver injury by regulating hepatic metabolic profiles and modulating gut microbiota. International Journal of Biological Macromolecules. 285. 138345–138345. 4 indexed citations
11.
Zhang, Xue, et al.. (2023). Multiple-model machine learning identifies potential functional genes in dilated cardiomyopathy. Frontiers in Cardiovascular Medicine. 9. 1044443–1044443. 2 indexed citations
12.
Xu, Xiaoyan, Meiting Jiang, Yu Wang, et al.. (2023). Multiple heart-cutting two-dimensional liquid chromatography/charged aerosol detector assay of ginsenosides for quality evaluation of ginseng from diverse Chinese patent medicines. Journal of Chromatography A. 1708. 464344–464344. 7 indexed citations
13.
Zhang, Lele, Rongrong Li, Liming Wang, et al.. (2023). Integration of UHPLC/Q-OrbitrapMS-based metabolomics and activities evaluation to rapidly explore the anti-inflammatory components from lasianthus. Heliyon. 9(6). e16117–e16117. 2 indexed citations
14.
Li, Xuejuan, Mengfan Wu, Hui Ding, et al.. (2023). Integration of non-targeted multicomponent profiling, targeted characteristic chromatograms and quantitative to accomplish systematic quality evaluation strategy of Huo-Xiang-Zheng-Qi oral liquid. Journal of Pharmaceutical and Biomedical Analysis. 236. 115715–115715. 3 indexed citations
15.
Wang, Qi, et al.. (2022). Tandem expression of Ganoderma sinense sesquiterpene synthase and IDI promotes the production of gleenol in E. coli. Applied Microbiology and Biotechnology. 106(23). 7779–7791. 3 indexed citations
16.
Pang, Xu, Liping Kang, Heshui Yu, et al.. (2012). New kaurene diterpenoid glycosides from fenugreek seeds. Natural Product Research. 27(13). 1202–1207. 9 indexed citations
17.
Zhang, Lijuan, Heshui Yu, Liping Kang, et al.. (2012). Two new steroidal saponins from the biotransformation product of the rhizomes ofDioscorea nipponica. Journal of Asian Natural Products Research. 14(7). 640–646. 12 indexed citations
18.
Li, Yingfei, Meng Wang, Xiaoying Wang, et al.. (2011). Pharmacokinetic properties of albiflorin and paeoniflorin after oral administration of pure compound, RadixPaeoniae albaextract and Danggui-Shaoyao-San extract to rats. Journal of Asian Natural Products Research. 13(2). 117–127. 22 indexed citations
19.
Pang, Xu, Heshui Yu, Liping Kang, et al.. (2011). Spirostanol Saponins Derivated from the Seeds ofTrigonella foenum-graecumbyβ-Glucosidase Hydrolysis and Their Inhibitory Effects on Rat Platelet Aggregation. Planta Medica. 78(3). 276–285. 15 indexed citations
20.
Feng, Bing, Ping Liu, Heshui Yu, et al.. (2010). Hydrolysis of timosaponin BII by the crude enzyme fromAspergillus nigerAS 3.0739. Journal of Asian Natural Products Research. 12(11). 955–961. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026